Dr. Neogi has returned to the ACR Committee on Quality of Care as its new chair after years of dedicated work developing classification criteria, outcome measures and treatment guidelines for rheumatoid arthritis, gout and other rheumatic diseases.
In November, the CMS finalized 12 MIPS Value Pathways (MVP) in the Quality Payment Program, including a rheumatology MVP. In 2023, clinicians can opt to report via traditional MIPS, the rheumatology MVP or both.
The ACR RISE Registry staff highlights need-to-know information and key changes for the 2023 performance year as outlined in the proposed rule released July 7.
The CMS has reopened the MIPS Extreme and Uncontrollable Circumstances applications for groups, virtual groups and Alternative Payment Model Entities are now open through March 31.
The ACR highlights essential information for providers for 2022 MIPS reporting in the 2022 Medicare Physician Fee Schedule Final Rule, published Nov. 2.
The new rheumatology-specific Merit-Based Incentive Payment System Value Pathway will focus on measures that most rheumatologists already track. The model should streamline reporting and better target quality improvements.
The final rule, issued Nov. 2, finalizes many proposed policies, including a decreased conversion factor, billing for shared visits and teaching services, continuation of telehealth services and inclusion of an ACR-led Merit-Based Incentive Payment System Value Pathway.
The MIPS Value Pathways will streamline federal reporting to better incentivize quality improvement. Start preparing for MVP with this session at ACR Convergence 2021.
The field of rheumatology is leading the way in the Centers for Medicare and Medicaid Services’ new MIPS Value Pathways with rheumatology-specific quality measures and improvement activities.